Skip to main content
. Author manuscript; available in PMC: 2020 Jun 11.
Published in final edited form as: Oncogene. 2019 Dec 11;39(11):2275–2289. doi: 10.1038/s41388-019-1141-7

Figure 3. CCR2 knockdown enhances tumoral expression of CD154 and decreases CCL2 expression.

Figure 3.

PyVmT mammary tumors treated with Con-si or CCR2-si were immunostained for A.CCR2, B. CD154 or C. CCL2 expression. Staining was quantified by ImageJ and normalized to hematoxylin staining (total area); arbitrary units are shown. Scalebar = 100 microns. N=6 mice per group, with four images per sample. Statistical analysis was performed using 2-tailed T test. Mean±SEM are shown.